Ratings by Chardan
| Date | Analyst | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Daniil Gataulin | EyePoint Inc. | EYPT | Maintain | Buy (N/A) |
29.00 (27.00) |
|
Details | |
| 3/4/2026 | Keay Kakae | Arbutus Biopharma | ABUS | Maintain | Buy (N/A) |
5.00 (N/A) |
|
Details | |
 |
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
|
|||||||||
| 961 more... | |||||||||
